Table 1.
Variable | Target value | Abnormal |
---|---|---|
Peak (exercise capacity) | ≥ 85% based on pred. or > 20 mL O2/min/kg | < 85%/ < 70%/ < 50% (mild/moderate/severe) |
/WR (aerobic capacity) | ≥ 9–10 mL/min/watt1 | ≤ 8 mL/min/watt |
at AT | ≥ 40–80% pred. (usually 50–65% of peak ) | < 40%/ < 30%/ < 25% (mild/moderate/severe) |
Blood pressure | Increase by 10 mmHg per 30 watts | Decrease, inadequate increase |
O2 pulse (/HR)2 | ≥ 80% | < 70% pred. during peak exercise |
Heart rate reserve (HRR) | ≥ 85% pred. (< 15 bpm) | < 85% predicted (but wide range) |
Breathing reserve (BR) | ≥ 15–20% (or ≥ 11–15 L/min) | < 15–20% (or < 11–15 L/min) |
Breathing frequency (BF) | ≤ 50/min | ≥ 60/min |
EqCO2 at AT | 25–30 at AT, ≤ 40 after AT | ≥ 35 at AT, > 40 after AT; |
EqO2 at AT | 20–30 at AT, ≤ 40 after AT | ≥ 35 at AT, > 40 after AT |
slope | 25–30 (slightly lower than EqCO2 at AT) | ≥ 35 or < 20 |
RER | ≥ 1.05 (ill) or ≥ 1.1 (healthy); > 1.1–1.5 in recovery phase; at rest: > 0.7, < 1.0 | < 1 (peak exercise) |
PETCO2 (≈ PACO2 ≈ PaCO2) | > 35 mmHg (at rest); > 40 mmHg (during exercise) | < 33 mmHg (at rest), < 3 mmHg increase or > 50 mmHg (peak exercise) |
PETO2 (≈ PAO2) | ≥ 90 mmHg (at rest), 20–30 mmHg increase during exercise | Lack of increase or decrease during exercise |
P(A-a) O23 | 20 mmHg (at rest); 30 mmHg (during exercise) | > 35 mmHg |
P(a-ET) CO24 | At rest: minimally positive; during exercise: slightly negative | > 5 mmHg |
a arterial, A alveolar, AT anaerobic threshold, bpm beats/minute, CO2 carbon dioxide, Eq ventilatory equivalent, ET end-tidal, HR heart rate, O2 oxygen, P pressure, pred. predicted, RER respiratory exchange rate, ventilatory equivalent for carbon dioxide, oxygen uptake, WR work rate
1Peak in obesity should be expressed as L/min or referenced to weight predicted
2O2 pulse (V̇O2/HR) peak exercise values vary widely by the same factors that affect normal peak and HR (e.g., age, body size, gender, Hb concentration, work rate, fitness level)
3P(A-a)O2 indicates efficacy of O2 uptake. PAO2 is calculated using the alveolar air formula (requires PaCO2 from blood gas analysis [BGA]), PaO2 is also determined using BGA
4P(a-ET)CO2 indicates efficacy of CO2 output to the alveoli: PACO2 is measured as PETCO2; PaCO2 is determined by BGA. P(a-ET)CO2 is slightly positive at rest due to V/Q inhomogeneities (poorly perfused upper lung areas with impaired CO2 production, PaCO2 > PACO2), and negative due to hyperventilation during exercise (PaCO2 < PACO2 [difference approximately 4 mmHg])